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ABSTRACT 29 
The purpose of this cross sectional study was to identify the prevalence of incontinence 30 
and incontinence-associated dermatitis in Australian acute care patients, describe the 31 
products worn to manage incontinence, and products at the bedside to provide perineal skin 32 
care. Data were collected over two days at major Australian teaching hospital on 376 33 
inpatients. The mean age of the sample was 62 years and 52% were male. The prevalence 34 
rate of incontinence was 24% (91/376). Urinary incontinence was significantly more 35 
prevalent in females (10%) than males (6%) (χ2=4.458, df =1, p = .035) Incontinence-36 
associated dermatitis occurred in 10% (38/376) of the sample, with 42% (38/91) of 37 
incontinent patients having incontinence-associated dermatitis. Semi-formed and liquid 38 
stool were associated with incontinence-associated dermatitis (χ2 =5.520, df =1 p=.027). 39 
Clinical indication of fungal infection was present in 32% (12/38) of patients with 40 
incontinence-associated dermatitis. Absorbent disposable briefs were the most common 41 
incontinence aids worn (80%, 70/91), with soap/ water and disposable washcloths the most 42 
commonly available (60%, 55/91) clean–up products present at the bedside. Further data 43 
are needed to validate this high prevalence. Studies that address prevention of 44 
incontinence-associated dermatitis and effectiveness of management strategies are also 45 
needed.  46 
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KEY MESSAGES 82 
• Nearly 1 in 4 hospitalized adults experience incontinence with more than 40% of 83 
those having incontinence-associated dermatitis (IAD). 84 
• Semi-formed and liquid stool are associated with IAD. 85 
• Older patients are significantly more likely to experience incontinence than 86 
younger patients.  87 
• More data are needed about IAD prevalence and management in the acute care 88 
setting in Australia.               89 
• This is the first Australian study to report both the prevalence of incontinence and 90 
IAD in the acute care setting and to differentiate IAD from pressure injury and 91 
clinical indication of fungal infection.  92 
 93 
94 
INTRODUCTION  95 
           Incontinence-associated dermatitis (IAD) is a complex, painful condition that is 96 
expensive and hard to treat (1, 2). It occurs in the perineum, labial folds, groin, upper 97 
thighs, buttocks, rectal area and gluteal cleft, as well as areas where increased friction 98 
occurs between skin and clothing or skin and absorptive devices (3, 4). IAD is 99 
characterised by inflammation and erythema, and may have blisters, erosion, denudation or 100 
serous exudate (2, 5). This results in high cost to the individual in pain and suffering, 101 
increased morbidity, and increased length and cost of the hospital stay (5).  102 
         Until recently, there was no international agreement on the name of the condition, its 103 
definition, or its implications for clinical practice. However, in 2007 a seminal consensus 104 
document by Gray et al (2) defined IAD as the response of the skin to chronic exposure to 105 
urine and faecal materials (inflammation and erythema with or without erosion or 106 
denudation). This definition acknowledges the source of the irritant, the response of the 107 
skin to that irritant and that an area beyond the perineum is commonly affected.  The 108 
standardised definition will allow researchers and clinicians to generate and compare data 109 
using a uniform conceptualization of the condition.  110 
Excess moisture on the skin acts as an irritant and contributes to skin breakdown 111 
and increased susceptibility to pressure injury from friction and shear (1-4, 6, 7). Moisture 112 
damaged skin can be vulnerable to secondary infection with Candida albicans or coliform 113 
bacteria (3). Wearing an absorptive containment product (pad) causes occlusion, resulting 114 
in increased (more alkaline) baseline skin pH, increased moisture from perspiration, and 115 
compromised skin barrier function (2, 8). The alkaline pH of urine promotes activity of the 116 
digestive enzymes lipases and proteinases in faeces, which in turn makes keratin in the 117 
stratum corneum vulnerable to breakdown (3). Wet skin is less resistant to injury from 118 
friction, and is at increased risk of erosion from rubbing on bed linens or incontinence pads 119 
(3, 8, 9).  Exposure to both faeces and urine is more damaging to skin than exposure to 120 
urine alone (10).    121 
Identification of IAD depends on skin inspection and accurate differentiation 122 
between other skin lesions, particularly pressure injury. Studies indicate that the 123 
differential diagnosis between a pressure injury and IAD is difficult, with IAD frequently 124 
misclassified by nurses as a pressure injury (1, 11). In fact, the National Pressure Ulcer 125 
Advisory Panel (NPUAP) recommends that the stage II pressure injury category should not 126 
be used to describe skin tears, tape burns, perineal dermatitis, maceration or excoriation 127 
(12). IAD also needs to be differentiated from intertriginous dermatitis, a moisture 128 
associated skin injury resulting from trapped moisture and friction in skin folds. (1, 3, 6, 129 
13). IAD has further been confused with  fungal or bacterial infections as well as other 130 
dermatological conditions (14). Misclassification of these lesions can result in poor patient 131 
outcomes as well as in inappropriate and ineffective use of health care resources (15). The 132 
primary goal of prevention and treatment for IAD is to minimise skin exposure to irritants 133 
(3).  134 
Understanding IAD requires an appreciation of incontinence, a condition associated 135 
with significant morbidity, decreased quality of life as well as being a burden for carers 136 
and the health care system. Urinary incontinence is an  involuntary leakage of urine (16) 137 
and while no consensus definition exists for faecal incontinence, its generally accepted 138 
definition is involuntary loss of solid or liquid stool (17). Incontinence occurs more 139 
frequently in older adults, although it can affect any age group (9, 18). Further, faecal 140 
incontinence is the second leading cause of admission to long-term care in the United 141 
States (19).   142 
Prevalence of incontinence among patients in the acute care setting is estimated to 143 
range from 10 to 37% (9, 18, 20).  Incontinence in the critical care environment ranges 144 
from 12% to 30% (21, 22) and in long-term acute care settings is 22% for urinary 145 
incontinence and 57% for faecal incontinence (23). Limited data exists identifying the 146 
scope of incontinence or demographic variables associated with incontinence in the 147 
Australian acute care setting. 148 
IAD also presents challenges for the acute care setting where the prevalence ranges 149 
from 20 to 50% (8, 9, 22-24). The prevalence of IAD in adults in Australian acute care 150 
hospitals   is not known.  Prospective Australian data are needed to provide insights into 151 
the scope of both incontinence and IAD in the acute care setting to aid health care 152 
providers in the development of prevention and management strategies. 153 
AIMS  154 
            The purpose of this study was to explore incontinence and IAD in the Australian 155 
acute care hospital setting. Specific research aims were to: 156 
• identify the prevalence of incontinence (urine and faecal), 157 
• identify the prevalence of IAD, and 158 
• describe the products worn to manage incontinence and products at the bedside to 159 
provide perineal skin care. 160 
METHODS 161 
Study Design 162 
            A cross-sectional study design was used. 163 
Study setting and sample 164 
            This study was conducted at a 929-bed major acute care teaching hospital in 165 
southeast Queensland, Australia. The facility provides acute care over a comprehensive 166 
range of specialities including medicine, surgery, orthopaedics, oncology, obstetrics, 167 
gynaecology, intensive care, burns and trauma. It is the largest tertiary referral hospital in 168 
Queensland, providing care in 2012 to almost 94,000 inpatients (25). 169 
Hospitalized adults aged 18 years and older admitted to the facility were eligible 170 
for inclusion. Patients were surveyed from Internal Medicine, Surgery, Critical Care 171 
(which includes a 36 bed intensive care unit and an 18 bed transit ward attached to the 172 
emergency department), Cancer Care and Women’s and Newborns (only adults were 173 
surveyed from this service) admitting services.  Patients from maternity and mental health 174 
services were excluded from the study.   175 
Operational definitions  176 
• Incontinence is the inability to control the flow of urine and/or stool any time in the 177 
preceding 24 hours (9). Patients with indwelling urinary catheters were deemed 178 
continent of urine for the analysis. The presence of a urinary catheter prevents urine 179 
from coming into contact with skin, and therefore removes the source of irritation 180 
(urine) necessary for the development of IAD.  Patients with faecal containment 181 
devices were deemed incontinent of faeces due to the high likelihood of faecal 182 
leakage from the containment device resulting in faecal contact with skin. These 183 
categorisations are consistent with previous studies (9, 26).  184 
• IAD is the presence of any skin redness with or without erosion due to skin contact 185 
with urine and/or faeces (rather than other sources of moisture) on the buttocks, 186 
coccyx, rectal area, scrotum, labia, lower abdomen, upper thighs, gluteal cleft or 187 
groins in an incontinent patient (2).  188 
• Fungal infection is based on the clinical presentation of a central maculopapular 189 
rash with characteristic satellite lesions in patients with IAD (3, 27). No 190 
microbiological testing was performed to confirm the presence of a fungal infection 191 
in this study. This is consistent with current clinical practice, as well as a previous 192 
IAD study (9). Diagnosis of superficial fungal infection relies more heavily on 193 
clinical findings and less on laboratory support (28, 29).  194 
• Pressure injuries are a localised injury to the skin and /or underlying tissue, usually 195 
over a bony prominence, as a result of pressure, or pressure in combination with 196 
shear (12). Pressure injuries were staged according to the Australian pressure injury 197 
staging guidelines at the time of data collection (30). 198 
Measures 199 
Continence Status and Products: Continence status, incontinence containment, clean-up 200 
and skin protection products as well as demographic data were recorded on a data 201 
collection instrument that was designed by the Principal Investigator (JC), based on a 202 
literature review. The instrument was pilot tested with 10 registered nurses at the research 203 
site and face validity established. Minor changes to the wording and layout of the 204 
continence section of the tool were made based on feedback from the pilot group. 205 
Demographic data collected were age, gender and admitting service. 206 
Stool Quality Assessment. Stool quality was measured based on the Bristol Stool form 207 
scale, but collapsed into dichotomas variables;  formed, which equates to type 1- 4 on the 208 
Bristol Stool form scale, and semiformed-liquid; equates to type 5-7 (31). 209 
IAD Severity: IAD severity was measured  by clinicians with the Skin Assessment 210 
Tool (SAT) (32). This tool does not require the patient to report symptoms (5, 6), nor does 211 
it assess pain. The SAT was designed to derive a cumulative IAD severity score with a 212 
numerical score assigned according to severity within each of three categories: skin 213 
redness, area of skin breakdown (cm²) and erosion. A cumulative severity score (maximum 214 
score = 10) is the sum of the scores for the three categories. It has good inter-rater 215 
reliability (κ =0.81 95% CI, 0.69-0.87) (33). Word descriptors were assigned to match 216 
numerical severity categories. Numerical cut-off points for each category were determined 217 
by consensus from a panel of experts comprising the authors and three wound care 218 
clinicians with 40 combined years of experience in the specialty. The cut points are 0 = no 219 
IAD, 1-3 = mild IAD; 4-6 = moderate IAD; 7-9 = severe IAD, 10 = extreme IAD.  220 
PROCEDURES 221 
           Prior to data collection, all research assistants (RAs) (n=30; 28 RNs, an 222 
occupational therapist and a medical practitioner) were trained in identification of IAD, 223 
pressure injury, and fungal infection. Interrater reliability was established at the conclusion 224 
of the education session by scores on a multiple-choice test of clinical photographs of a 225 
variety of IAD lesions, pressure injuries and fungal infections. The test required 226 
participants to differentiate between IAD, pressure injury, and a fungal infection as well as 227 
classify the IAD images according to the study instrument. A score of 80% was required 228 
for the RA to participate in the study. The use of photographs to test inter-rater reliability 229 
has previously been used (11, 34, 35).  RAs also were trained in study procedures.    230 
This study was conducted over two consecutive days in November 2011 by the 231 
principal investigator (JC) and 30 RAs.  Skin inspections were conducted by the RAs on all 232 
eligible, consenting patients. The incontinent management product the patient was wearing 233 
was recorded. Each patient’s buttocks, coccyx, rectal area, scrotum, labia, lower abdomen, 234 
upper thighs, gluteal cleft and groins was inspected and loss of skin integrity classified as 235 
IAD, pressure injury, or clinical indication of fungal infection. Continence data were 236 
collected and for those who were incontinent, type of incontinence was obtained from the 237 
patient, primary nurse and/or clinical records. Stool quality and frequency data collected 238 
were collected for faecally incontinent patients from the patient, primary nurse and/or 239 
clinical records. Data were also recorded on the type of incontinence clean up and skin 240 
protection products at the bedside. When patients were absent from the ward at the time of 241 
data collection, the RAs returned and included those present when possible. Demographic 242 
data were collected on all patients. To assure accuracy, the principal investigator who is a 243 
skin integrity expert conducted an independent pelvic girdle inspection on all cases 244 
identified by the RAs as having IAD and validated the SAT score.  245 
ETHICAL CONSIDERATIONS 246 
            The study was approved by the Human Research Ethics Committees for both the 247 
research site and the university. Written information about the study was distributed to all 248 
eligible patients the day prior to data collection. Patients provided verbal consent as 249 
required by the Human Research Ethics Committees.  250 
STATISTICAL METHODS 251 
             Participants were assigned a study number and all data were de-identified.  Data 252 
were entered into Statistical Packages for Social Sciences (SPSS) (Version 20.0, Armonk, 253 
NY, USA). A random 10 per cent of data entry was crosschecked for accuracy. Incomplete 254 
data were coded as missing data.  255 
Descriptive statistics were used to describe study variables (means and standard 256 
deviations for continuous variables; frequencies and percentages for categorical variables). 257 
Prevalence of incontinence was calculated by the total number of incontinent patients in 258 
the sample divided by the total number of study patients. Prevalence of IAD was calculated 259 
by the total number of IAD cases in the sample divided by the total number of study 260 
participants.  Prevalence of IAD among incontinent patients was calculated by the total 261 
number of IAD cases divided by the total number of incontinent participants. Bivariate 262 
analysis using descriptive correlational statistics (Chi-square test for independence with 263 
Yates continuity correction and Fisher’s exact test where expected cell counts were less 264 
than five) were used to explore characteristics of sample with incontinence and IAD. p 265 
values less than 0.05 were considered statistically significant. Direct logistic regression 266 
analysis was performed to predict whether independent variables gender, admitting service 267 
and age predict the outcome, incontinence. The variables entered into the model were 268 
based on what is known about incontinence, in particular association with increasing age, 269 
association with being female and the prevalence of geriatric syndromes, specifically 270 
incontinence in medical patients (18). In addition, selection of these independent variables 271 
facilitates comparison of our results with other studies providing clinical applicability.  The 272 
Hosmer-Lemeshow test was used to examine the goodness of fit of the logistic regression 273 
model. 274 
RESULTS 275 
           Of the 552 patients assessed for eligibility (Table 1), 545 patients were eligible, 379 276 
patients consented to take part and were surveyed. Data for 376 patients were included in 277 
the analysis (Figure 1). Three patients were excluded from analyses, as the screening tool 278 
was not completed. The mean age of the sample was 62 (SD 19.3) years and 52% (n=194) 279 
of patients were male. Patients were admitted most frequently to the internal medicine 280 
(44%, n= 167) and surgical services (39%, n=146) (Table 2). The Hosmer-Lemeshow test 281 
was used to examine the goodness of fit of the logistic regression model. The result was 282 
non-significant, χ2 (8) = 3.03, p = .932, indicating that the model fit was satisfactory.     283 
Prevalence of Incontinence 284 
            The prevalence of incontinence was 24% (91/376) (Table 2). Double incontinence 285 
(urinary and faecal) was most common (12%, 46/376), followed by faecal incontinence 286 
(8%, 32/279), with the prevalence of urinary incontinence only was 3.5% (13/376). 287 
Urinary catheters were present in 13% (49/376) of patients. Faecal incontinence was more 288 
prevalent in females (11%, 43/376) than males (9%, 35/376). Urinary incontinence was 289 
significantly more prevalent in females (10%) than males (6%) (χ2=4.458, df =1, p = .035), 290 
however, the reason for urinary catheter placement was not determined by this study, so 291 
the prevalence of urinary incontinence may be underestimated. Direct logistic regression 292 
was performed to assess the impact of a number of factors on incontinence. The model 293 
contained three independent variables (age, gender and admitting service). The full model 294 
containing all predictors was statistically significant χ2 (6, N=376) = 31.48, p < 0.001. 295 
Gender made no difference to the odds of having incontinence (OR = 0.85, p = .516) 296 
(Table 3). Older patients had a greater likelihood of having incontinence compared to 297 
younger patients (OR = 1.03, p < .001). Patients in the Surgical admitting service were less 298 
likely to have incontinence, compared to patients in the Internal Medicine admitting 299 
service (OR = 0.51, p = .029). Internal medicine and other admitting services showed no 300 
difference in the likelihood of patients having incontinence (p > .05) (Table 3).  301 
Prevalence of Incontinence-Associated Dermatitis 302 
            IAD was present in 10% (38/376) of the sample and the prevalence of IAD in those 303 
who were incontinent was 42% (38/91) (Table 2). Among incontinent patients, chi-square 304 
analysis showed that there was no significant association between type of incontinence 305 
(urinary verses faecal) and IAD (χ2 =7.237, df =1 p=.007). Among patients with IAD, chi-306 
square analysis showed that patients with semi-formed or liquid stool were more likely to 307 
have IAD than those patients with formed stool (χ2 =5.520, df =1 p=.027). Faecal 308 
frequency and IAD were not significantly associated (χ2 = 3.536, df =1 p=.116) (Table 4).   309 
Mild skin redness was present in 84% (32/38) of patients with IAD, a small area of skin 310 
breakdown occurred in 32% (12/38), mild erosion was present in 32% (12/38) of patients,  311 
while 50% (19/38) of patients had no erosion. The most common anatomical locations for 312 
skin injury were buttocks (42%, 16/38), followed by the rectal area (34 %, 13/38). The 313 
SAT severity score showed 82% (31/38) were suffering from mild IAD, 13% (5/38) were 314 
suffering from moderate IAD, 6% (2/38) were suffering from severe IAD, and no patients 315 
suffering from extreme IAD (Table 5).  316 
         Clinical indication of fungal infection was present in 32% (12/38) of patients with 317 
IAD. However, presence of fungal infection may have been over or underestimated as no 318 
microbiological testing to confirm the diagnosis of fungal infection was undertaken in this 319 
study. Pressure injuries were present in 6% (22/376) patients, with 21% (8/38) patients 320 
with IAD having a pressure injury (Table 5).  321 
Products worn to manage incontinence and products used to provide perineal skin 322 
care. 323 
            Wrap-around incontinent briefs or pads (i.e. those aids worn as an alternative to 324 
underwear) were  worn by 77% (70/91) of incontinent patients at the time of evaluation 325 
(Table 6).Soap/water and disposable washcloths were the most common incontinence 326 
clean-up products at the bedside for incontinent patients (60%, 55/91). Moisturising agents 327 
were present at the bedside in 34% (31/91) of incontinent patients. Skin protection 328 
products were present at the bedside in 57% (52/91) patients. Examples of these products 329 
are 3M™ Cavilon™ No Sting Barrier Film (3M, Saint Paul, MN) and Skin Basics™ Zinc 330 
and Castor Oil Cream (Biotech Pharmaceuticals, Victoria, Australia).  331 
DISCUSSION 332 
            Incontinence occurred in 1 in 4 patients hospitalised in a major acute care setting in 333 
Australia, indicating it is a frequent and serious problem. IAD occurs in 42% of those who 334 
are incontinent, demonstrating that IAD is a prevalent and under-appreciated skin injury in 335 
hospitalized patients. The most common incontinence aid worn was an incontinent brief 336 
(80%), with soap/water and disposable cloths the most common incontinence clean-up 337 
present at the bedside (60%). This is the first Australian study to report both the prevalence 338 
of incontinence and IAD in the acute care setting and to differentiate IAD from pressure 339 
injury and fungal infection.  340 
Incontinence-Associated Dermatitis 341 
             Acute care patients are subjected to treatment regimes that may result in IAD, for 342 
example, antibiotics, changes in dietary intake and enteral feeds. Thus, acute care patients 343 
are a unique population that are at increased risk. IAD has been under-appreciated as is not 344 
the primary reason for admission. Anecdotal evidence suggests it is not only accepted, but 345 
actually expected that older patients will be incontinent. 346 
IAD prevalence data for the general acute care setting is limited. The majority of 347 
published data are drawn from specialised settings such as critical care or the aged care 348 
setting. A study in three urban hospital critical care units found an IAD prevalence of 36% 349 
(36) and prevalence in a long-term acute care setting was 23%, (23). Prevalence of IAD 350 
ranges in aged care from 6%-22% (10, 37).  351 
An important finding to emerge from our study is that liquid and semi-formed stool 352 
was associated with IAD compared to formed stool. No other published studies examined 353 
the association between stool quality and IAD. Congruent with our finding, the extensive 354 
review by Gray and associates (8)    identify that stool is implicated as an aetiological 355 
factor in IAD; with clinical experience strongly suggesting that liquid stool is more 356 
irritating than solid or formed stool. Further research is warranted to determine if stool 357 
quality, particularly semi-formed/liquid stool, promotes the development of IAD. 358 
Most IAD severity in our study was mild (82%, 31/38). Junkin and Selekof (9) 359 
classified IAD as red and dry, red and weepy, or having blisters in the areas likely to be 360 
exposed to urine or faeces. Of the patients with IAD, 75% (18/24) had red and dry skin, 361 
with 25% (6/24) having red and weepy skin. Both of these categories could be interpreted 362 
as being at the less severe end of a severity continuum, which correlates with the severity 363 
of IAD in our study. The natural history of IAD is poorly understood (2), but progression 364 
from ‘mild’ through to ‘severe’ IAD  is inevitable in the presence of persisting 365 
incontinence, inadequate management of incontinence and inadequate or inappropriate 366 
incontinence clean-up, skin protection and treatment of any secondary cutaneous 367 
infections. Early recognition and treatment thus is optimum. 368 
IAD needs to be differentiated from other skin lesions, especially in the pelvic 369 
girdle. Pressure injuries historically have been confused with IAD. The NPUAP and the 370 
European Pressure Ulcer Advisory Panel (EPUAP) have specifically stated that IAD is not 371 
a pressure injury (12). A strength of this study is that both IAD and pressure injury were 372 
identified, so accurate prevalence of each could be determined. Future pressure injury 373 
prevalence studies would benefit from also measuring incontinence and IAD. 374 
Presence of urine and faeces on denuded skin creates a favourable environment for 375 
development of fungal infection, with fungal infection frequently reported as a potential 376 
complication of IAD (2, 7, 27). The presence of a secondary fungal infection needs to be 377 
differentiated form IAD. Presence of fungal infection for our study was    determined based 378 
on clinical presentation of a central maculopapular rash with characteristic satellite lesions 379 
(3). No quantitative microbiological testing was undertaken. According to Professor Jack 380 
Sobel (personal email, jsobel@med.wayne.edu, 3rd April 2014) the fungal rash may also 381 
present as non-specific, confluent and papular, creating some difficulty in clinical 382 
diagnosis. The presence of a secondary fungal infection would require treatment, but is 383 
desirable obtain a microbiological culture prior to commencing anti-mycotic therapy (28, 384 
29, 38). Accordingly, the presence of a secondary fungal infection may have been under or 385 
overestimated in our study. Our data showed 32% (12/38) patients with IAD demonstrated 386 
clinical evidence of a fungal infection. This is higher than the United States data from 387 
Junkin and Selekof (9) that showed 10% of incontinent patients had a fungal rash (based 388 
on clinical examination). The higher prevalence of suspected fungal infection in our study 389 
may be associated with the higher IAD prevalence rate. These infections are a serious 390 
threat to patient outcomes because of the possibility of under-diagnosis or missed 391 
diagnosis, and the potential for delay in treatment.  It is not clear whether a fungal infection 392 
may have an aetiological role in IAD, rather than being a secondary infection. 393 
Pressure injuries were present in 6% of our entire sample, with 12% of incontinent 394 
patients having a pressure injury. This prevalence is lower than that reported by Junkin and 395 
Selekof (9) where 22% of incontinent patients had a pressure injury. In part, our lower 396 
pressure injury rate may reflect the increased emphasis on pressure injury prevention in 397 
recent years.  398 
One of the issues in the literature continues to be the lack of a universal definition 399 
for IAD prevalence. That is to say, should the denominator be the entire sample, or only 400 
those with incontinence? Since IAD cannot occur without incontinence (that is, skin 401 
exposure to urine and or faeces) (2), the number of incontinent patients logically would be 402 
the denominator. Most studies report IAD prevalence with the denominator being the 403 
number of incontinent patients (9, 22, 33), but a consistent standard needs to be 404 
established. However, we recommend that until a standard definition is accepted, that 405 
researchers present the IAD rate for the entire sample and for those who are incontinent to 406 
ensure clarity and accuracy. We have used that approach in this paper.  407 
Incontinence  408 
          The definition of incontinence for an IAD prevalence study needs further 409 
clarification, specifically, how to categorise patients who have a urinary catheter. The 410 
presence of a urinary catheter prevents skin exposure to urine – a known cause of IAD.  411 
Previous studies have categorised patients with urinary catheters as continent (9, 26). 412 
However, it should be acknowledged that categorising patients with a urinary catheter as 413 
continent can result in an underestimation of incontinence prevalence. In the acute care 414 
setting, patients can be catheterised for a multitude of reasons including incontinence. For 415 
example in this study, 11 of 15 patients surveyed in ICU had urinary catheter. The use of a 416 
urinary catheter in ICU is to monitor kidney function, fluid balance in the critically ill.  417 
        Our data show a significant association between increasing age and incontinence. 418 
Junkin and Selekof (9) found the odds of older patients having incontinence were greater 419 
(OR 4.979, 95% CI 1.015-22.427). Incontinence is recognised as one of the geriatric 420 
syndromes (18, 39) and has been associated with longer length of hospital stay and greater 421 
risk of being discharged to a residential care setting (40-42). Ageing of the global 422 
population (43) coupled with the rising cost of health care (43-45) means that managing 423 
incontinence in the acute care setting is an ever-increasing challenge. 424 
 The limited prospective prevalence data for incontinence in the acute cares setting 425 
in Australia is noteworthy, since incontinence is associated with significant morbidity and 426 
decreased quality of life for individuals (39). Health care providers require an 427 
understanding of the magnitude of a condition to provide appropriate care. We are not 428 
certain why the probability of incontinence is lower in the surgical admitting service than 429 
the Internal Medicine admitting service, although there is  some evidence supporting 430 
increased prevalence of geriatric syndromes (including incontinence) in older medical 431 
patients in acute care setting (18).  Our study adds important results that assist in 432 
understanding the burden of incontinence in the Australian acute care setting. 433 
Products worn to manage incontinence and products used to provide perineal skin 434 
care. 435 
            Our study showed disposable incontinence briefs were the most common 436 
incontinence aids worn (77%), soap/water and disposable washcloths the most common 437 
clean-up products at the bedside (60%), and skin barrier protection available at the bedside 438 
of 57% of patients. A consistent, structured approach to prevention and treatment of IAD is 439 
required (2, 3). Having supplies at the bedside provides an efficient approach and ensures 440 
that a consistent strategy is used. Three steps are recommended: (i), gentle cleansing, using 441 
a soft disposable washcloth and cleansers without perfumes or irritants and close to skin 442 
pH (a no rinse formulation is suggested); (ii)  moisturisation to preserve the lipid barrier 443 
(3), and (iii), application of a skin barrier product is required to protect the stratum 444 
corneum from moisture and irritants (3, 6). Lack of bedside supplies suggests there is a gap 445 
between available products/recommendations and care. Further research is needed to 446 
identify how products are used, as well as their effectiveness in preventing and treating 447 
IAD.  448 
LIMITATIONS 449 
           Several limitations need to be noted. This is a cross-sectional study and no cause 450 
and effect can be inferred. Every effort was made to recruit eligible participants; however, 451 
direct clinical examination of patients in this type of study can be intrusive and may have 452 
limited enrolment, (in our study, this was 69%). Data was not recorded as to why patients 453 
refused to participate. This study did not have ethical approval to collect data from those 454 
patients who did not consent. The IAD Severity Assessment tool was chosen in this study 455 
to classify severity of the condition. However, this scale does not include a measure of 456 
patient pain. IAD and faecal  quality analysis was conducted at a bivariate level as the 457 
amount of missing data in these variables made adjusting for confounders and logistic 458 
regression analysis unfeasible. Clinical inspection was used to determine the presence of 459 
fungal infection in this study. The prevalence of fungal infection may have been over or 460 
underestimated as no quantitative laboratory measure was used to confirm the diagnosis. 461 
Future research needs to use appropriate quantitative measures to confirm the presence of 462 
fungal infection.  463 
CONCLUSION 464 
           This is the first Australian study to report both the prevalence of incontinence and 465 
IAD in the acute care setting and to differentiate IAD from pressure injury and fungal 466 
infection. Almost one quarter of hospitalized adults were incontinent, and of the 467 
incontinent patients in the study, more than 40% developed IAD. Faecal incontinence 468 
occurred more frequently than urinary incontinence. Liquid and semi-formed stool was 469 
significantly associated with IAD compared to formed stool. In addition, our data 470 
confirmed that the likelihood of incontinence increases with age, especially in those >80. 471 
Products for incontinence containment, clean up, and skin protection need to be available 472 
at the bedside to facilitate incontinence management. Further, prospective observational 473 
prevalence studies are essential to confirm these data in hospitalized Australian adults. The 474 
availability of results informing the prevalence of both incontinence and IAD is essential to 475 
measure the scope of the problem. More research addressing the effectiveness of treatment 476 
of incontinence and IAD in the acute care setting is needed. Additional research examining 477 
the aetiology of IAD and the role of fungal infections is warranted. 478 
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Figure1. Patient recruitment and participant diagram. 521 
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 540 
Patients assessed for eligibility n=552 
Data available for analysis n = 376 
Excluded (total) 
1. Ineligible 
      <18 years old n = 7 
2. Eligible but not recruited 
     Refused to participate n = 
166 
Total patients recruited n = 379 
Data set incomplete n = 3 
 541 
 542 
 543 
 544 
 545 
Table 1; Characteristics of patients assessed for eligibility (n = 552) 546 
 547 
* Only adults were evaluated from this admitting service. 548 
 549 
 550 
 551 
 552 
 553 
 554 
 555 
 556 
 557 
 558 
559 
Admitting 
Service 
Male 
Number 
 (%) 
Female 
Number 
(%) 
Patients 
assessed for 
eligibility  
Age  
(mean) 
Standard 
deviation 
 
Internal 
Medicine 
100 (46.3) 116 (53.7) 216 68.2 17.2 
Surgical 
Services 
140 (65.4) 74 (34.6) 214 55.5 19.4 
Cancer Care 39 (58.2) 28 (41.8) 67 61.3 17.8 
Critical Care 
(includes 
Intensive Care 
and Emergency 
Medicine) 
19 (47.5) 21 (52.5) 40 48.8 19.3 
Women’s and 
Newborn* 
0 (0) 15 (100) 15 50.4 18.4 
Total 298 254 552 56.8 22.7 
 560 
Table 2. Sample characteristics 561 
 Sample  n=376 
Incontinent 
patients 
 n=91 
Patients with IAD 
n=38 
Age (mean, standard 
deviation) 
62 (19.3) 70 (17.4) 74.8 (15.3) 
Gender, number (%)    
Male 194 (51.6) 41 (45) 13 (34.2) 
Female 182 (48.4) 50 (54.9) 25 (65.8) 
Indwelling urinary 
catheter present number, 
(%) 
49 (13) 23 (25.3) 9 (23.7) 
Admitting Service 
(number, %) 
   
Internal Medicine 167 (44.4) 55 (60.4) 23 (60.5) 
Surgical Services 146 (38.8) 21 (23.1) 8 (1.1) 
Critical Care (includes 
Intensive Care and 
Emergency Medicine) 
21 (7.7) 6 (6.6) 3 (7.9) 
Cancer Care 29 (7.7) 6 (6.6) 2 (5.3) 
Women’s and 
Newborns* 
13 (3.5) 3 (3.3) 2 (5.3) 
 562 
* Only adults were evaluated from this admitting service. 563 
 564 
 565 
566 
 567 
Table 3. Predictors of incontinence (n= 376). 568 
 569 
Characteristics 
and Intercept  
Coefficient 
β 
Standard 
Error 
Wald Chi-
Square P value OR 95% CI 
Intercept -2.750 .617 19.226 <.001 .067  
Gender 
 (Ref: Female) 
      
 Male -.168 .259 .421 .516 0.85 (0.51, 1.4) 
Age .029 .008 13.610 <.001 1.03 (1.01, 1.05) 
Admitting  
service 
 (Ref: Internal   
 Medicine) 
      
  Critical Care .272 .537 .257 .612 1.31 (0.46, 3.76) 
  Surgery -.670 .308 4.745 .029 0.51 (0.28, 0.94) 
  Cancer Care -.508 .496 1.048 .306 0.60 (0.23, 1.59) 
  Women and   
  Newborns † 
-.189 .712 .070 .791 0.83 (0.2, 3.34) 
CI, confidence interval: OR, odds ratio 570 
† Only adults were evaluated from this admitting service. 571 
 572 
573 
 574 
        Table 4. Clinical characteristics of incontinent patients (n=91) 575 
        and patients with IAD (n=38) 576 
 577 
*Percentages may not add up to 100 due to rounding 578 
 579 
580 
Variable 
Incontinent 
patients 
n=91 
Patients with 
IAD n=38 
Urinary Incontinence   
Male, number (%)  6 (6.6) 1(2.6) 
Female number (%)  7 (7.8) 0 (0) 
Faecal Incontinence    
Male number (%)   18 (19.8) 5 (13.1) 
Female number (%)   14 (15.4) 10 (26.3) 
Double (urine and faecal) incontinence   
Male 17 (18.7) 7 (18.4) 
Female 29 (31.9)* 15 (39.5)* 
Faecal Quality number (%)   
Formed  5 (5.5) 0 (0) 
Semi-formed or liquid  36 (39.6) 19 (50) 
Missing 50 (54.9) 19 (50) 
Faecal Frequency number (%)   
< 3 day  13 (14.3) 5 (13.2) 
3 or more per day  28 (30.8) 17 (44.7) 
Missing 50 (54.9) 16 (42.1) 
 581 
 582 
         Table 5. Characteristics, location and severity of IAD (n=38) 583 
 n             % 
Skin Redness    
Mild 32 84.2 
Moderate 4 10.5 
Severe 2 5.3 
Area of skin breakdown    
None 19 50.0 
Small  13 34.2 
Moderate 2 5.3 
Large 4 10.5 
Skin Erosion    
None 19 50.0 
Mild 18 47.4 
Moderate 1 2.6 
Severe 0     0 
Extreme 0 0 
Area Affected *   
Buttocks 16 42.1 
Coccyx 5 13.2 
Gluteal Cleft 4 10.5 
Groins 6 15.8 
Lower abdomen 3 7.9 
Rectal 13 34.2 
Scrotum/labia 7 18.4 
Upper thighs 2 5.3 
IAD Severity Score   
1-3 Mild IAD  31 81.6 
4-6 Moderate IAD  5 13.1 
7-9 Severe IAD  2 5.3 
> 9 Extreme IAD  0 0 
Pressure injury 8 21.1 
Clinical indication of fungal infection  12 31.6 
 584 
*Total > 100% as patients may have more than one area affected. 585 
 586 
 587 
 588 
 589 
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 592 
 593 
 594 
 595 
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 598 
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 600 
 601 
Table 6. Products worn to manage incontinence and products used to provide perineal skin 602 
care (n = 91) 603 
Variable n % 
Incontinent aid worn    
Urinary incontinence   
• None 2 2.2 
• Wrap around pad 4 4.4 
• Pull up pad 5 5.5 
• Insert pad 1 1.1 
Faecal incontinence   
• None 11 12.1 
• Wrap around pad 10 11.0 
• Pull up pad 8 8.8 
• Insert pad 1 1.1 
Double Incontinence   
• None 1 1.1 
• Wrap around pad 21 23.1 
• Pull up pad 22 24.2 
• Insert pad 1 1.1 
Incontinent aid- missing  4 4.4* 
Incontinence clean-up (number, %)   
• Soap/water and disposable cloth  55 60.4 
• Missing 36 39.6 
Moisturiser (number, %)   
• Yes 31 34.1 
• No 22 24.2 
• Missing 38 41.7 
Skin protection products (number, %)   
• Yes 52 57.1 
• Missing 39 42.8* 
* Percentages may not add up to 100 due to rounding604 
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